(Q88454081)
Statements
A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19) (English)
0 references
18 years old
0 references
75 years old
0 references
the clinical trial ChiCTR2000029381